Double maintains 3 strategies that include CRSP - CRISPR Therapeutics AG
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JMBS | 0.01% | $5.55B | 0.22% |
BOND | -0.05% | $5.67B | 0.7% |
GBIL | -0.10% | $6.37B | 0.12% |
TOTL | 0.11% | $3.84B | 0.55% |
TIPZ | 0.13% | $94.79M | 0.2% |
FLDR | 0.17% | $941.22M | 0.15% |
JMST | 0.18% | $4.06B | 0.18% |
IBMP | -0.18% | $553.65M | 0.18% |
VMBS | -0.24% | $14.48B | 0.03% |
SHYD | 0.25% | $332.63M | 0.35% |
NUBD | 0.27% | $397.77M | 0.16% |
FXE | 0.31% | $568.94M | 0.4% |
SPMB | -0.32% | $6.16B | 0.04% |
IBD | -0.32% | $385.27M | 0.43% |
SCHP | -0.36% | $12.99B | 0.03% |
CGSD | -0.46% | $1.32B | 0.25% |
MMIN | -0.65% | $336.10M | 0.3% |
JBND | -0.65% | $2.32B | 0.25% |
SMMU | 0.70% | $892.02M | 0.35% |
OWNS | -0.72% | $129.31M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 79.43% | $1.02B | 0.75% |
GNOM | 75.42% | $44.57M | 0.5% |
XBI | 67.45% | $4.82B | 0.35% |
ARKK | 64.74% | $6.85B | 0.75% |
IBB | 61.09% | $5.26B | 0.45% |
IWC | 59.81% | $818.14M | 0.6% |
PBE | 59.53% | $223.19M | 0.58% |
IWO | 59.36% | $11.60B | 0.24% |
IWM | 57.41% | $63.72B | 0.19% |
KOMP | 57.36% | $2.29B | 0.2% |
VTWO | 57.35% | $12.52B | 0.07% |
VBK | 56.81% | $19.01B | 0.07% |
SCHA | 56.37% | $17.26B | 0.04% |
QQQJ | 56.33% | $621.52M | 0.15% |
ISCG | 56.33% | $681.20M | 0.06% |
KJAN | 55.98% | $287.30M | 0.79% |
VXF | 55.76% | $22.29B | 0.05% |
KJUL | 55.71% | $119.50M | 0.79% |
NUSC | 55.30% | $1.14B | 0.31% |
ESML | 55.14% | $1.84B | 0.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -19.18% | $24.23B | +35.36% | 1.09% |
ED | -16.66% | $36.00B | +12.64% | 3.34% |
MO | -14.98% | $99.67B | +28.77% | 6.90% |
CME | -14.41% | $99.39B | +40.68% | 3.86% |
DUK | -13.89% | $90.99B | +17.25% | 3.56% |
EXC | -11.61% | $43.33B | +23.58% | 3.62% |
T | -10.10% | $203.71B | +51.55% | 3.92% |
LITB | -9.80% | $21.24M | -78.57% | 0.00% |
K | -8.26% | $27.76B | +41.17% | 2.85% |
PM | -7.81% | $273.81B | +73.45% | 3.06% |
BTCT | -7.18% | $25.56M | +61.14% | 0.00% |
AWK | -7.06% | $27.36B | +9.65% | 2.21% |
PSQH | -7.04% | $98.82M | -36.55% | 0.00% |
AEP | -6.71% | $55.16B | +17.93% | 3.54% |
ZCMD | -6.70% | $29.55M | -8.59% | 0.00% |
PGR | -5.64% | $151.13B | +22.60% | 1.89% |
SO | -5.44% | $100.18B | +17.28% | 3.18% |
VHC | -4.94% | $48.19M | +108.24% | 0.00% |
KO | -4.91% | $305.22B | +11.97% | 2.81% |
AMT | -4.74% | $104.32B | +14.40% | 3.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -50.39% | $296.22M | 1.43% |
VIXY | -38.28% | $164.54M | 0.85% |
TAIL | -36.78% | $99.63M | 0.59% |
IVOL | -25.60% | $347.03M | 1.02% |
SPTS | -17.72% | $5.80B | 0.03% |
FTSD | -17.53% | $231.81M | 0.25% |
LDUR | -16.31% | $929.65M | 0.5% |
SCHO | -14.49% | $11.03B | 0.03% |
UTWO | -14.30% | $379.52M | 0.15% |
FXY | -13.60% | $816.38M | 0.4% |
STPZ | -13.56% | $450.47M | 0.2% |
VGSH | -13.39% | $22.80B | 0.03% |
XONE | -13.35% | $625.28M | 0.03% |
ULST | -13.27% | $654.75M | 0.2% |
IBTG | -13.22% | $1.92B | 0.07% |
SHYM | -12.71% | $357.13M | 0.35% |
IBTH | -12.61% | $1.62B | 0.07% |
IBTI | -12.10% | $1.06B | 0.07% |
IBTJ | -11.53% | $688.19M | 0.07% |
IEI | -10.72% | $15.48B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RXRX | 72.37% | $2.12B | -29.12% | 0.00% |
BEAM | 71.28% | $2.00B | -15.33% | 0.00% |
NTLA | 67.18% | $1.11B | -53.25% | 0.00% |
ABCL | 62.26% | $1.12B | +38.38% | 0.00% |
CRBU | 61.63% | $127.42M | -14.38% | 0.00% |
ALLO | 60.47% | $262.48M | -42.31% | 0.00% |
TWST | 57.51% | $2.26B | -21.50% | 0.00% |
SITE | 56.30% | $5.78B | +9.30% | 0.00% |
DNLI | 55.30% | $2.16B | -30.05% | 0.00% |
FATE | 55.25% | $128.39M | -64.56% | 0.00% |
DNA | 53.76% | $703.03M | -15.71% | 0.00% |
EYPT | 53.08% | $664.72M | +12.07% | 0.00% |
SDGR | 52.68% | $1.54B | +4.28% | 0.00% |
COHU | 52.11% | $953.77M | -38.54% | 0.00% |
LSCC | 51.92% | $7.19B | -16.13% | 0.00% |
IMNM | 51.30% | $750.92M | -28.80% | 0.00% |
TXG | 51.20% | $1.62B | -30.61% | 0.00% |
IPGP | 50.94% | $3.12B | -13.24% | 0.00% |
EDIT | 50.52% | $214.31M | -45.06% | 0.00% |
KLIC | 49.94% | $1.94B | -25.30% | 2.20% |
Current Value
$52.361 Year Return
Current Value
$52.361 Year Return
Yahoo
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best CRISPR stocks to buy. Following CRISPR Therapeutics AG (NASDAQ:CRSP)’s supplemental update to its Phase 1 CTX310 trial findings, H.C. Wainwright reaffirmed its Buy rating and $65 price target on the company on June 27. According to the latest results, CTX310, an in vivo ANGPTL3 knockout therapy, continues […]
Yahoo
CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (NASDAQ: CRSP) and Viking Therapeutics (NASDAQ: VKTX), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period.
Yahoo
These companies are poised to produce fireworks for your portfolio over the coming years.
Yahoo
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO), today announced the promotion of Laura Sandler to Chief Operating Officer. Ms. Sandler, who joined Oruka in 2024 as SVP of Operations, brings over 20 years of biopharmaceutical leadership experience across clinical operat
Finnhub
CRISPR Therapeutics AG added to Russell 3000 Value Index...
Finnhub
CRISPR Therapeutics AG added to Russell 2500 Value Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VSA | -0.03% | $8.67M | -19.04% | 0.00% |
TSN | 0.07% | $20.06B | +1.50% | 3.46% |
WRB | 0.07% | $26.84B | +36.70% | 0.46% |
MSIF | -0.10% | $769.47M | +36.17% | 7.61% |
PRA | -0.15% | $1.17B | +89.68% | 0.00% |
CL | -0.23% | $74.88B | -3.64% | 2.19% |
WEC | -0.24% | $33.11B | +33.56% | 3.32% |
BULL | -0.27% | $6.47B | +25.76% | 0.00% |
BTI | 0.28% | $103.67B | +50.78% | 6.33% |
GIS | 0.29% | $29.20B | -14.66% | 4.47% |
DFDV | 0.32% | $300.56M | +2,130.16% | 0.00% |
KDP | -0.34% | $45.96B | +3.42% | 2.72% |
MCK | 0.37% | $88.11B | +20.93% | 0.40% |
GFI | 0.41% | $21.56B | +57.55% | 2.31% |
CCEC | 0.43% | $1.02B | +3.91% | 2.58% |
PG | -0.47% | $377.94B | -1.61% | 2.53% |
IMNN | -0.53% | $16.26M | -34.16% | 0.00% |
KMB | 0.56% | $43.92B | -3.75% | 3.75% |
ADC | 0.61% | $7.93B | +16.41% | 4.21% |
NEE | 0.63% | $150.32B | +1.66% | 2.95% |